Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.40 |
| ▸ | FNTB | P49356 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 7/20 | 0.32 |
| ▸ | CA2 | P00918 | 7/20 | 0.32 |
| ▸ | CA9 | Q16790 | 7/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA3 | P07451 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA6 | P23280 | 2/20 | 0.31 |
| ▸ | CA5A | P35218 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 2/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5969147 | 0.94 | FNTA (0.46) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL5969124 | 0.88 | FNTA (0.35) | FNTAFNTB | |
| SCHEMBL1706206 | 0.82 | FNTA (0.49) | FNTAFNTB | |
| SCHEMBL452928 | 0.79 | FNTA (0.39) | FNTAFNTB | |
| SCHEMBL15845914 | 0.79 | TP53 (0.33) | CA1CA2CA9CA12CA3 | |
| SCHEMBL8717347 | 0.77 | FNTA (0.56) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL11897599 | 0.75 | GAA (0.33) | — | |
| SCHEMBL15846410 | 0.74 | CA1 (0.34) | CA1CA2 | |
| SCHEMBL15017838 | 0.74 | ALDH1A1 (0.43) | — | |
| SCHEMBL1029720 | 0.74 | APP (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6406687-B1 | POLYOXYALKYLENE ETHER, SULFATE, SULFONATE AND SULFAMATE AS ANTICOAGULANTS | BIOINTERACTIONS LTD. (GB) | 2002-06-18 | — | — | US | claimed |
| US-6096798-A | COATING MATERIALS FOR MEDICAL DEVICES, SUCH AS TUBING OR CONNECTORS | BIOINTERACTIONS LTD. (GB) | 2000-08-01 | — | — | US | claimed |
| EP-0896600-B1 | NON-THROMBOGENIC AND ANTI-THROMBOGENIC POLYMERS | LUTHRA AJAY KUMAR (GB) | 2000-01-12 | — | — | EP | claimed |
| EP-0896600-A1 | NON-THROMBOGENIC AND ANTI-THROMBOGENIC POLYMERS | Luthra, Ajay Kumar (GB) | 1999-02-17 | — | — | EP | claimed |
| WO-1997041164-A1 | NON-THROMBOGENIC AND ANTI-THROMBOGENIC POLYMERS | LUTHRA AJAY KUMAR (GB) | 1997-11-06 | — | — | WO | claimed |
| US-RE49528-E1 | Bioactive coatings | BIOINTERACTIONS LTD. (GB) | 2023-05-16 | — | — | US | disclosed |
| US-RE49522-E1 | Bioactive coatings | BIOINTERACTIONS LTD. (GB) | 2023-05-09 | — | — | US | disclosed |
| CN-114957564-A | Bioactive coating | 生物相互作用有限公司 | 2022-08-30 | — | — | CN | disclosed |
| EP-3699220-A1 | BIOACTIVE COATINGS | Biointeractions Ltd (GB) | 2020-08-26 | — | — | EP | disclosed |
| CN-110776610-A | Bioactive coating | 生物相互作用有限公司 | 2020-02-11 | — | — | CN | disclosed |
| US-10206945-B2 | Bioactive coatings | BIOINTERACTIONS LTD. (GB) | 2019-02-19 | — | — | US | disclosed |
| EP-2988790-A1 | BIOACTIVE COATINGS | Biointeractions Ltd. (GB) | 2016-03-02 | — | — | EP | disclosed |
| WO-2014174237-A1 | BIOACTIVE COATINGS | BIOINTERACTIONS LIMITED (GB) | 2014-10-30 | — | — | WO | disclosed |
| US-20140322287-A1 | BIOACTIVE COATINGS | BIOINTERACTIONS LTD. (GB) | 2014-10-30 | — | — | US | disclosed |
| US-7034061-B1 | Non-thrombogenic and anti-thrombogenic polymers | BIOINTERACTIONS LTD. (GB) | 2006-04-25 | — | — | US | disclosed |
| US-6406687-B1 | POLYOXYALKYLENE ETHER, SULFATE, SULFONATE AND SULFAMATE AS ANTICOAGULANTS | BIOINTERACTIONS LTD. (GB) | 2002-06-18 | — | — | US | disclosed |
| US-6096798-A | COATING MATERIALS FOR MEDICAL DEVICES, SUCH AS TUBING OR CONNECTORS | BIOINTERACTIONS LTD. (GB) | 2000-08-01 | — | — | US | disclosed |
| EP-0896600-B1 | NON-THROMBOGENIC AND ANTI-THROMBOGENIC POLYMERS | LUTHRA AJAY KUMAR (GB) | 2000-01-12 | — | — | EP | disclosed |
| EP-0896600-A1 | NON-THROMBOGENIC AND ANTI-THROMBOGENIC POLYMERS | Luthra, Ajay Kumar (GB) | 1999-02-17 | — | — | EP | disclosed |
| WO-1997041164-A1 | NON-THROMBOGENIC AND ANTI-THROMBOGENIC POLYMERS | LUTHRA AJAY KUMAR (GB) | 1997-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140322287-A1 | BIOACTIVE COATINGS | SERPINC1, PLAT, FGB | FNTA 1407/4885FNTB 2133/4885CA1 3240/4885 |
| US-10206945-B2 | Bioactive coatings | SERPINC1, PLAT, FGB | FNTA 1407/4885FNTB 2133/4885CA1 3240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.